Client News
Filter by:
- Nov 7 2023 MAIA Biotechnology Reports Third Quarter 2023 Financial Results and Highlights Recent Development Progress for Anticancer Asset THIO
- Nov 7 2023 Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results
- Nov 6 2023 Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 6 2023 Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
- Nov 6 2023 Foresight: Eye-Net and SoftBank Corp. Successfully Complete First Phase of Cross-Collision Prevention V2X Project in Japan
- Nov 6 2023 Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
- Nov 6 2023 Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study
- Nov 3 2023 Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Nov 3 2023 Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
- Nov 2 2023 BRAEMAR HOTELS & RESORTS ANNOUNCES UPDATES ON PROPERTY LEVEL MORTGAGES